Suchergebnisse - "Atanasoff, Kristina E"

PubPharm (5)

1

An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody

enthalten in: mBio | 2024

von Atanasoff, K. | Brambilla, L. | Adelsberg, D. | +13

UpdateOf: bioRxiv. 2023 Apr 21;:. - PMID 37131698

2

The CD46 ectodomain participates in human cytomegalovirus infection of epithelial cells

enthalten in: The Journal of general virology | 2023

von Parsons, A. | Stein, K. | Atanasoff, K. | +3

3

Anin vitroexperimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies

enthalten in: bioRxiv.org | 2023

von Atanasoff, K. | Brambilla, L. | Adelsberg, D. | +11

4

An in vitro experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies

enthalten in: bioRxiv : the preprint server for biology | 2023

von Atanasoff, K. | Brambilla, L. | Adelsberg, D. | +11

UpdateIn: mBio. 2023 Dec 6;:e0247723. - PMID 38054729

5

Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus

enthalten in: Antiviral research | 2023

von Parsons, A. | Ophir, S. | Gardner, T. | +12

1
[1]